Gene Mutation May Guard Against Diabetes

Researchers have discovered a genetic mutation that may prevent type 2 diabetes from developing, even in patients at high risk for the disease.

Using this discovery, researchers hope to identify a “drug target,” allowing them to develop a new strategy for prevention and treatment of the disease. 

In a genetic analysis of 150,000 patients, an international team of researchers followed select participants who, despite severe risk for diabetes, never developed the disease. 

________________________________________________________________________________________________________________________________________________________________________

RELATED CONTENT
Impact of SGLT2 Inhibitors on Type 2 Diabetics Examined
Genetic Link Between Coronary Heart Disease Risk and Diabetes

________________________________________________________________________________________________________________________________________________________________________

Focusing on a gene previously identified to play a role in the development of diabetes, researchers used new forms of genetic sequencing to search for mutations.

They identified 2 separate, rare mutations in SLC30A8 that halted the function of the gene, appearing to reduce the risk of diabetes development and lower blood sugar in non-diabetics.  

Eventually, 10 more separate, rare mutations were discovered having similar effects, leading researchers to conclude that inheriting 1 form of defective SLC30A8 led to a 65% reduced risk of diabetes development. 

These mutations disrupt function of the ZnT8 protein found within SLC30A8, which transports zinc into insulin-producing beta cells.  How the loss of function protects against diabetes development is still unknown. 

“This work underscores that human genetics is not just a tool for understanding biology: it can also powerfully inform drug discovery by addressing one of the most challenging and important questions — knowing which targets to go after,” researchers concluded.

–Michael Potts

References:

1. Bridger H. Study pinpoints protective mutations for type 2 diabetes [press release]. March 2, 2014. http://www.broadinstitute.org/news/5570

2. Flannick J Thorleifsson G, Beer N, Jacobs S, et al.  Loss-of-function mutations in SLC30A8 protect against type 2 diabetes.    Nature Genetics. doi:10.1038/ng.2915